Number of Shares
5.23 Mil
Current Holdings Value*
$211.87 Mil
% of Portfolio
7.11%
Total Estimate Gain
$130.04 Mil
% of Total Estimate Gain
79.07%

GENERAL ATLANTIC, L.P.'s Akero Therapeutics Inc Holding Summary

As of 2025-03-31, GENERAL ATLANTIC, L.P. held 5.23 Mil shares of Akero Therapeutics Inc(AKRO), totaling $211.87 Mil. This investment constitutes 7.11% of their stock portfolio, and GENERAL ATLANTIC, L.P. now holds 6.57% of the outstanding Akero Therapeutics Inc(AKRO) stock.

The initial trade took place in 2023Q2. And since then GENERAL ATLANTIC, L.P. has made 2 purchases of AKRO, at an average price of $31.42, for a total of 5.23 Mil shares. Based on historical transaction data and AKRO's current price of $56.27, GENERAL ATLANTIC, L.P.'s estimated gain on his AKRO holdings is $130.04 Mil, reflecting a 79.07% gain to date.

GENERAL ATLANTIC, L.P. AKRO ($56.27) Holding Chart

GENERAL ATLANTIC, L.P. AKRO ($56.27) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1